Microbiota transplant therapy and autism: lessons for the clinic

References

• Adams JB, Audhya T, Mcdonough-Means S, et al. Nutritional and metabolic status of children with Autism vs. Neurotypical children, and the association with autism severity. Nutr Metab (Lond). 2011 Jun;8:8(1):34.
   Google Scholar
• Chaidez V, Hansen RL, Hertz-Picciotto I. Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord. 2014;44(5):1117–1127.
   PubMed Web of Science ®Google Scholar
• Holingue C, Newill C, Lee LC, et al. Gastrointestinal symptoms in autism spectrum disorder: A review of the literature on ascertainment and prevalence. Autism Res. 2018 Jan;11(1):24–36. Epub 2017 Aug 30.
   PubMed Web of Science ®Google Scholar
• Adams JB, Audhya T, Geis E, et al. Comprehensive nutritional and dietary intervention for autism spectrum disorder—a randomized, controlled 12-month trial. Nutrients. 2018 Mar 17;10(3):E369. .
   PubMed Web of Science ®Google Scholar
• Imperatore N, Tortora R, Morisco F, et al. Gut microbiota and functional diseases of the gastrointestinal tract. Minerva Gastroenterol Dietol. 2017 Dec;63(4):355–372.
   PubMed Web of Science ®Google Scholar
• Adams JB, Johansen LJ, Powell LD, et al. Gastrointestinal flora and gastrointestinal status in children with autism – comparisons to neurotypical children and correlation with autism severity. BMC Gastroenterol. 2011;11:22. 2011 Mar 16.
   PubMed Web of Science ®Google Scholar
• Fulceri F, Morelli M, Santocchi E, et al. Gastrointestinal symptoms and behavioral problems in preschoolers with autism spectrum disorder. Dig Liver Dis. 2016 Mar;48(3):248–254. Epub 2015 Dec 11.
   PubMedGoogle Scholar
• Khoruts A, Brandt LJ. Fecal microbiota transplant: a rose by any other name. Am J Gastroenterol. 2019;114:1176.
   PubMed Web of Science ®Google Scholar
• Staley C, Khoruts A, Sadowsky MJ. Contemporary applications of fecal microbiota transplantation to treat intestinal diseases in humans. Arch Med Res. 2017 Nov;48(8):766–773. Epub 2017 Nov 26. .
   PubMed Web of Science ®Google Scholar
• Choi HH, Cho YS. Fecal microbiota transplantation: current applications, effectiveness, and future perspectives. Clin Endosc. 2016 May;49(3):257–265. Epub 2016 Mar 9. .
   PubMed Web of Science ®Google Scholar
• Khoruts A, Dicksved J, Jansson JK, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol. 2010;44:354–360.
   PubMed Web of Science ®Google Scholar
• van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407–415.
   PubMed Web of Science ®Google Scholar
• Vaughn BP, Rank KM, Khoruts A. Fecal microbiota transplantation: current status in treatment of GI and liver disease. Clin Gastroenterol Hepatol. 2019;17:353–361.
   PubMed Web of Science ®Google Scholar
• Kelly JR, Kennedy PJ, Cryan JF, et al. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015;9:392.
   PubMed Web of Science ®Google Scholar
• Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23:716–724.
   PubMed Web of Science ®Google Scholar
• van Kessel SP, Frye AK, El-Gendy AO, et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease. Nat Commun. 2019;10:310.
   PubMed Web of Science ®Google Scholar
• Dodd D, Spitzer MH, Van TW, et al. A gut bacterial pathway metabolizes aromatic amino acids into ni, ne circulating metabolites. Nature. 2017;551:648–652.
   PubMed Web of Science ®Google Scholar
• Kang DW, Ilhan ZE, Isern NG, et al. Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders. Anaerobe. 2018 Feb;49:121–131. Epub 2017 Dec 22. PMID: 29274915.
   PubMed Web of Science ®Google Scholar
• Krajmalnik-Brown. A fruitful discovery: can gut bacteria control hyperactive behavior? Mol Cell. 2019 2019 feb 7;73:395–397.
   PubMed Web of Science ®Google Scholar
• Borody T Bacteriotherapy for chronic fatigue syndrome. A long term follow-up study. CFS National Consensus Conference, Sydney; 1995.
   Google Scholar
• Borody TJ, Nowak A, Finlayson S. The GI microbiome and its role in chronic fatigue syndrome: A summary of bacteriotherapy. J Austral Coll Nutr Env Med. 2012;31:3–8.
   Google Scholar
• Thurm T, Ablin JN, Buskila D, et al. Fecal microbiota transplantation for fibromyalgia: a case report and review of the literature. Open J Gastroenterol. 2017;7:131–139.
   Google Scholar
• Sandler RH, Finegold SM, Bolte ER, et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol. 2000 Jul;15(7):429–435.
   PubMed Web of Science ®Google Scholar
• Isaac SS, JU, Djukovic A, et al. Short- and long-term effects of oral vancomycin on the human intestinal microbiota. J Antimicrob Chemother. 2017;72:128–136.
   PubMed Web of Science ®Google Scholar
• Andrews P, Borody TJ, Shortis NP, et al. Bacteriotherapy for chronic constipation – long term follow-up. Gastroenterology. 1995;108:A563.
   Web of Science ®Google Scholar
• Borody TJ. Probiotic recolonisation therapy. US Patent 8,460,648B2; 2013.
   Google Scholar
• Kang DW, Adams JB, Gregory AC, et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017 Jan 23;5(1):10.
   PubMed Web of Science ®Google Scholar
• Kang DW, Adams JB, Coleman DM, et al. Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota. Sci Rep. 2019 Apr 9;9(1):5821. PMID: 30967657.
   PubMed Web of Science ®Google Scholar
• Finegold SM, Molitoris D, Song Y, et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis. 2002 Sep 1;35(Suppl 1):S6–S16.
   PubMed Web of Science ®Google Scholar
• Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol. 2004 Nov;70(11):6459–6465.
   PubMed Web of Science ®Google Scholar
• Parracho HM. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. 2005;54(10):987–991.
   PubMed Web of Science ®Google Scholar
• De Angelis M, Piccolo M, Vannini L, et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS ONE. 2013;8(10):e76993.
   Web of Science ®Google Scholar
• Tomova A, Husarova V, Lakatosova S, et al. Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav. 2015;138:179–187.
   PubMed Web of Science ®Google Scholar
• Luna RA, Oezguen N, Balderas M, et al. Distinct microbiome-neuroimmune signatures correlate with functional abdominal pain in children with autism spectrum disorder. Cell Mol Gastroenterol Hepatol. 2017;3(2):218–230.
   PubMed Web of Science ®Google Scholar
• Finegold SM, Summanen PH, Downes, et al. Detection of Clostridium perfringens toxin genes in the gut microbiota of autistic children. Anaerobe. 2017;45:133–137.
   PubMed Web of Science ®Google Scholar
• Kong X, Liu J, Cetinbas M, et al. New and preliminary evidence on altered oral and gut microbiota in individuals with autism spectrum disorder (ASD): implications for ASD diagnosis and subtyping based on microbial biomarkers. Nutrients. 2019 Sep 6;11(9):E2128. .
   PubMed Web of Science ®Google Scholar
• FDA In Brief: FDA warns about potential risk of serious infections caused by multi-drug resistant organisms related to the investigational use of Fecal microbiota for transplantation, June 19, 2019. Available from 2019 Oct 12. https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-about-potential-risk-serious-infections-caused-multi-drug-resistant-organisms.
   Google Scholar
• Juneja M, Venkatakrishnan A, Kapoor S, et al. Autism spectrum disorders and celiac disease: is there an association? Indian Pediatr. 2018 Oct 15;55(10):912–914.
   PubMed Web of Science ®Google Scholar
• Kushak RI, Lauwers GY, Winter HS, et al. Intestinal disaccharidase activity in patients with autism: effect of age, gender, and intestinal inflammation. Autism. 2011 May;15(3):285–294. Epub 2011 Mar 17.
   PubMed Web of Science ®Google Scholar
• Piwowarczyk A, Horvath A, Łukasik J, et al. Gluten- and casein-free diet and autism spectrum disorders in children: a systematic review. Eur J Nutr. 2018 Mar;57(2):433–440. Epub 2017 Jun 13.
   PubMed Web of Science ®Google Scholar
• Testa A, Imperatore N, Rispo A, et al. Beyond irritable bowel syndrome: the efficacy of the low fodmap diet for improving symptoms in inflammatory bowel diseases and celiac disease. Dig Dis. 2018;36(4):271–280. Epub 2018 May 15.
   PubMed Web of Science ®Google Scholar
• Eswaran S, Chey WD, Jackson K, et al. A diet low in fermentable Oligo-, Di-, and monosaccharides and polyols improves quality of life and reduces activity impairment in patients with irritable bowel syndrome and diarrhea. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1890–1899.e3. Epub 2017 Jun 28.
   PubMed Web of Science ®Google Scholar